Additional pneumococcal vaccine doses are recommended for children and adults at increased risk of invasive disease. The Australian Immunisation Handbook 10th edition contains detailed recommendations.ChiuPublic health physicianClaytonPublic health physicianMcIntyre...
This study estimates the annual population-level impact of 13-valent pneumococcal conjugate vaccine (PCV13) infant national immunization programs (NIPs) on vaccine-type and non-vaccine type invasive pneumococcal disease (IPD) incidence across all ages using national surveillance data. Methods We identifi...
The introduction of the vaccine into the immunisation programme of industrialising countries, such as in South Africa, require robust surveillance to evaluate the effectiveness of the vaccine in such settings where the epidemiology of pneumococcal diseases differs to that in developed countries....
The Australian National Immunisation Program (NIP) provides free se... L Briggs,P Fronek,V Quinn,... - 《Vaccine》 被引量: 0发表: 2019年 Perceptions of influenza and pneumococcal vaccine uptake by older persons in Australia Influenza and pneumococcal vaccinations reduce adverse health outcomes in...
Observed changes in pneumococcal density might be temporal rather than vaccine related. Funding Department of Foreign Affairs and Trade of the Australian Government through the Fiji Health Sector Support Program; Victorian Government's Operational Infrastructure Support Program; Bill & Melinda Gates ...
The Impact of Pneumococcal Vaccination on Bacterial and Viral Pneumonia in Western Australian Children: Record Linkage Cohort Study of 469589 Births, 1996... Pneumococcal conjugate vaccine (PCV) was included in Australia's National Immunisation Program for all children from 2005. We assessed the impact...
Immunisation has contributed greatly to the control of vaccine-preventable diseases and therefore to improvements in health and survival, especially among young children, and remains one of the most successful and cost-effective public health interventions. This remains true for many of the newer, more...
Streptococcus pneumoniae remains a common cause of both non-invasive and invasive infection with high morbidity and mortality. The very young and the elderly are a particular risk of pneumococcal disease. There is considerable variation in virulence...
The Australian immunisation schedule uses 13-valent pneumococcal conjugate vaccine (PCV13), while New Zealand (NZ) changed from PCV13 to 10-valent PCV (PCV... N Hagedoorn,A Anglemyer,C Gilkison,... - 《Lancet Regional Health Western Pacific》 被引量: 0发表: 2023年 Changing epidemiology of...
pneumoniae vaccine and vaccine-related serotypes; impact upon lung function in children aged ≥6 years; and vaccine safety. Discussion As H. influenzae is the most common bacterial pathogen associated with these chronic respiratory diseases in children, a novel pneumococcal conjugate vaccine that also...